Endoscopy 2009; 41(2): 118-122
DOI: 10.1055/s-0028-1119452
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria

O.  Goto1 , M.  Fujishiro1 , S.  Kodashima1 , S.  Ono1 , M.  Omata1
  • 1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
Weitere Informationen

Publikationsverlauf

submitted 2 February 2008

accepted after revision 5 November 2008

Publikationsdatum:
12. Februar 2009 (online)

Preview

Background and study aims: Endoscopic submucosal dissection (ESD) is a novel, promising endoscopic technique for gastrointestinal neoplasms. We aimed to elucidate the feasibility of ESD as curative treatment for intestinal-type early gastric cancer (EGC) potentially without lymph-node metastases.

Patients and methods: For the short-term analysis, 276 consecutive, intestinal-type EGCs, which fulfilled the criteria for node-negative EGC in 231 patients who had undergone ESD from January 2000 to March 2007, were retrospectively investigated. For the long-term analysis, 212 lesions checked by endoscopy later than 1 year or recurrence within 1 year after ESD were assessed for local recurrence, and 208 patients followed for over 1 year or to death within 1 year after ESD were assessed for metastases and survival. All lesions/patients were divided into three groups: intramucosal cancer without ulcerative findings (M-Ul[−]); intramucosal cancer with ulcerative findings, ≤ 3 cm (M-Ul[+]); and slight invasive cancer into submucosa (< 500 µm), ≤ 3 cm (SM1).

Results: En bloc and complete resection rates were 96.7 % and 91.7 %, respectively. During a median follow-up of 36 months (range 2 – 93 months), two local recurrences occurred (0.9 %), which were detected at 2 and 6 months after ESD, respectively. During a median follow-up of 38 months (range 6 – 97 months), the 5-year overall and disease-specific survival rates were 96.2 % and 100 %, respectively, with neither lymph node nor other-organ metastasis; one patient died due to other disease 6 months after ESD. No disease-related death occurred. No significant differences were found between the groups in short- and long-term analyses.

Conclusions: The prognostic analyses demonstrated the validity of the criteria of node-negative intestinal-type EGC as curability criteria for ESD. ESD can be proposed as an alternative method to gastrectomy for the treatment of these EGCs.

References

M. FujishiroMD, PhD 

Department of Gastroenterology
Graduate school of Medicine
University of Tokyo

7-3-1, Hongo
Bunkyo-ku
Tokyo
Japan

Fax: +81-3-58008806

eMail: mtfujish-kkr@umin.ac.jp